Related Experiment Video
Updated: Aug 11, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic significance of ventricular late potentials in coronary artery disease
Insights
Ventricular late potentials (VLPs) are common in coronary artery disease (CAD) and significantly increase the risk of sustained ventricular tachycardia/fibrillation (VT/VF), especially in patients with ventricular aneurysm or a history of VT/VF.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Ventricular late potentials (VLPs) are potential indicators of arrhythmic risk.
- Their prevalence and prognostic significance in coronary artery disease (CAD) require further investigation.
Purpose of the Study:
- To determine the prevalence of VLPs in CAD patients.
- To assess the prognostic value of VLPs for sustained ventricular tachycardia/fibrillation (VT/VF).
Main Methods:
- High-gain electrocardiography (ECG) and signal-averaging techniques were used.
- VLPs were assessed in 92 CAD patients, with follow-up for VT/VF events.
Main Results:
- VLPs were detected in 35% of CAD patients, with higher prevalence in those with ventricular aneurysm (48%) or prior VT/VF (82%).
- Patients with VLPs had a significantly higher incidence of sustained VT/VF (31% vs 2%) and mortality from VT/VF (p < 0.01).
- VLP presence, length, and low ejection fraction were associated with increased arrhythmic risk.
Conclusions:
- VLPs are prevalent in CAD and are a significant predictor of future sustained VT/VF.
- VLP detection aids in risk stratification for sudden cardiac death in CAD patients.
Abstract:
By means of high-gain ECG and signal-averaging techniques, we tried to determine the prevalence and prognostic significance of ventricular late potentials (VLPs) in coronary artery disease (CAD). No VLPs were detected in normal subjects (n = 25) or in patients with various noncoronary cardiopathies with sustained ventricular tachycardia and/or fibrillation (VT/VF) (n = 10). Among 92 CAD patients, VLPs were apparent in 35% (32 of 92) at the beginning of the study. The prevalence of VLPs increased to 48% (19 of 40) in the presence of ventricular aneurysm (VA) and to 82% (14 of 17) in the presence of a history of previous sustained VT/VF. To determine the prognostic significance of VLPs, a prospective analysis was conducted during a mean of 7.4 months (range 1 to 22 months). During the follow-up period, 11 patients (12%) presented with an episode of sustained VT/VF, and six of them died from documented VT/VF. Three other patients died from cardiogenic shock. An episode of sustained VT/VF occurred in 31% (10 of 32) of the patients with VLPs vs 2% (1 of 58) of the patients without VLPs (p less than 0.001), and six patients with VLPs died from sustained VT/VF vs none in the group of patients without VLPs (p less than 0.01). This VLP-related increase in arrhythmic risk was still present in the particular subgroup of patients with a history of previous sustained VT/VF (n = 17) and in patients with VA (n = 40). The risk of developing sustained VT/VF was also influenced by the length of the VLP and by a low mean ejection fraction.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

